|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/6883 | (2018.01) |
| C12Q2600/106 | (2013.01) | ||
| C12Q 1/6883 | (2013.01) | ||
| C12Q2600/158 | (2013.01) | ||
| C12Q2600/156 | (2013.01) |
| (11) | Number of the document | 3695012 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18803806.1 |
| Date of filing the European patent application | 2018-10-11 | |
| (97) | Date of publication of the European application | 2020-08-19 |
| (45) | Date of publication and mention of the grant of the patent | 2023-03-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/055377 |
| Date | 2018-10-11 |
| (87) | Number | WO 2019/075181 |
| Date | 2019-04-18 |
| (30) | Number | Date | Country code |
| 201762570985 P | 2017-10-11 | US |
| (72) |
XIN, Yurong , US
GROMADA, Jesper , US
CHENG, Xiping , US
DEWEY, Frederick , US
TESLOVICH DOSTAL, Tanya , US
SCHURMANN, Claudia , US
BARAS, Aris , US
ABUL-HUSN, Noura , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | INHIBITION OF HSD17B13 IN THE TREATMENT OF LIVER DISEASE IN PATIENTS EXPRESSING THE PNPLA3 I148M VARIATION |
| INHIBITION OF HSD17B13 IN THE TREATMENT OF LIVER DISEASE IN PATIENTS EXPRESSING THE PNPLA3 I148M VARIATION |